Melanoma susceptibility and progression: Association study between polymorphisms of the chemokine (CCL2) and chemokine receptors (CX3CR1, CCR5).
Rodero
Mathieu
M
Rodero
Pauline
P
Descamps
Vincent
V
Lebbe
Céleste
C
Wolkenstein
Pierre
P
Aegerter
Philippe
P
Vitoux
Dominique
D
Basset-Seguin
Nicole
N
Dupin
Nicolas
N
Grandchamp
Bernard
B
Soufir
Nadem
N
Combadière
Christophe
C
Saiag
Philippe
P
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000073883:CX3C Chemokine Receptor 1; D018932:Chemokine CCL2 / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease / Q000453:epidemiology; D006801:Humans; D008297:Male; D008545:Melanoma / Q000453:epidemiology / Q000235:genetics*; D008875:Middle Aged; D019713:Receptors, CCR5 / Q000235:genetics*; D019707:Receptors, Chemokine / Q000235:genetics*; D012307:Risk Factors; D012878:Skin Neoplasms / Q000453:epidemiology / Q000235:genetics*
C111835:CCL2 protein, human; D000073883:CX3C Chemokine Receptor 1; C095235:CX3CR1 protein, human; D018932:Chemokine CCL2; D019713:Receptors, CCR5; D019707:Receptors, Chemokine